National Institute of Neurosciences & Hospital (NINS) is a state run tertiary care institute in Bangladesh focused on neurological disorders. It is located at Agargaon in Dhaka. Bangladeshi neurologist Prof Quazi Deen Mohammad is the founding director of this institute.
We present the discovery of a superjovian planet around the young A5 star HIP 54515, detected using precision astrometry from the Hipparcos Gaia Catalogue of Accelerations and high-contrast imaging with SCExAO/CHARIS from the recently commenced OASIS program. SCExAO/CHARIS detects HIP 54515 b in five epochs 0 . ″ 145–0 . ″ 192 from the star (∼3–4 λ / D at 1.65 μ m), exhibiting clockwise orbital motion. HIP 54515 b lies near the M/L transition with a luminosity of log( L / L ⊙ ) ∼−3.52 ± 0.03. Dynamical modeling constrains its mass and mass ratio to be 17.7 − 4.9 + 7.6 M Jup and 0.0090 − 0.0024 + 0.0036 and favors a ∼25 au semimajor axis. HIP 54515 b adds to a growing list of superjovian planets with moderate eccentricities ( e ≈ 0.4). Now, the third planet discovered from surveys combining high-contrast extreme adaptive optics imaging with precision astrometry, HIP 54515 b, should help improve empirical constraints on the luminosity evolution and eccentricity distribution of the most massive planets. It may also provide a key technical test of the Roman Space Telescope Coronagraph Instrument’s performance in the low stellar flux, small angular separation limit, and a demonstration of its ability to yield constrainable planet spectral properties.
In Bangladesh, more than a quarter of drinking water tubewells are contaminated with arsenic above the national standard (50 µg/l), while nearly half exceed the World Health Organization guideline (10 µg/l). Among other negative health consequences, arsenic is a suspected environmental risk factor for neural tube defects (NTDs), including spina bifida. Maternal folate status protects against NTDs, though recent evidence suggests arsenic attenuates folate’s protective effects. Arsenic is methylated prior to excretion with methyl groups produced in one-carbon metabolism, for which folate is a cofactor. We thus hypothesized that DNA methylation (DNAme) may provide insight into the interactions between arsenic, maternal folate levels, and offspring spina bifida. Here we analyzed leukocyte DNAme using the Illumina MethylationEPIC v2.0 array in 374 women from Bangladesh, 246 with a previous spina-bifida affected birth and 128 controls. Chronic arsenic exposure was evaluated in maternal toenail; fasting plasma folate was measured at blood draw. Linear models evaluated DNAme associated with offspring spina bifida, arsenic, folate, and their interaction terms. Maternal DNAme was associated with spina bifida at 71 CpGs, arsenic at 6 CpGs, and folate at 33 CpGs (all FDR < 0.05). The spina bifida*arsenic and arsenic*folate interactions were associated with 11 and 28 CpGs, respectively, while spina bifida*folate returned no significant associations. We observed lower DNAme in mothers of spina bifida cases at significant loci, including in developmental genes such as HOXB3 and HOXB4. Arsenic’s influence on DNAme was more pronounced in individuals with low folate. Our work suggests that postnatal maternal leukocyte DNAme is associated with offspring spina bifida status and is modified by arsenic exposure but not plasma folate. - Maternal DNA methylation is responsive to arsenic, folate, and offspring spina bifida. - Offspring spina bifida affects > 50 postnatal maternal DNA methylation loci. - DNA methylation at significant loci decreases with higher folate and with higher arsenic. - Arsenic*spina bifida and arsenic*folate interactions affect maternal DNA methylation. - Maternal DNA methylation is not significantly associated with folate*spina bifida.
Epilepsy is a common yet frequently misdiagnosed neurological disorder, with significant implications for morbidity, mortality, and quality of life. Despite advances in diagnostics and therapeutics, clinical decision-making in epilepsy continues to be challenged by early diagnostic uncertainty, inappropriate drug selection, and delayed referral for surgical evaluation. This presentation, “Epilepsy: Practical Pearls,” focuses on concise, high-yield clinical principles that guide everyday practice for physicians and subspecialists managing seizure disorders. Key themes include the critical distinction between a single seizure and epilepsy. Practical approaches to first seizure evaluation are discussed, highlighting the primacy of clinical history over EEG and neuroimaging. The session also reviews rational interpretation of EEG and the importance of epilepsy-protocol MRI in identifying structural etiologies. Syndrome-based diagnosis, as recommended by the International League Against Epilepsy, is underscored as essential for appropriate antiseizure medication selection as well as calculation of prognosis. Special emphasis is placed on avoiding drugs that may worsen seizure types, recognizing drug-resistant epilepsy early, and timely referral to specialized epilepsy centers. Surgical options, particularly in focal epilepsies, are highlighted as potentially curative but underutilized interventions. Additional focus is given to status epilepticus management and consideration of autoimmune, genetic, and structural etiologies in refractory cases. The presentation aims to enhance clinical accuracy, reduce diagnostic errors, and promote evidence-based, patient-centered epilepsy care through practical, immediately applicable clinical pearls. Bangladesh J Medicine 2026; Vol. 37, No. 2(1): pp. 190
Background: Mutation in the TP53 suppressor gene and accumulation of p53 protein are the common genetic events in gastric carcinomas. This mutation has been associated with abnormalities in cell cycle regulation, DNA repair and synthesis, apoptosis, and is suggested to be implicated in the prognosis of gastric carcinoma. Objective: The purpose of the present study was to assess the immunohistochemical expression of p53 protein in gastric adenocarcinoma and to study the association between p53 protein expression and tumour staging, including depth of invasion and regional lymph node involvement. Methodology: In this cross-sectional observational study, 60 paraffin blocks of gastric adenocarcinoma were re-evaluated, and depth of invasion and regional lymph node involvement were assessed. The p53 expression in the tumour cell nucleus of the submitted blocks was assessed by the standard immunoperoxidase method. Appropriate positive control were run for each batch of slides. Results: In this study, out of 60, forty cases (66.67%) showed high expression of p53 protein. Our study showed a statistically significant association of p53 protein expression with depth of invasion of tumour (p < 0.001) and regional lymph node involvement (p < 0.001). Conclusion: There was a significant association between immunohistochemical expression of p53 protein and tumour staging, including depth of invasion of tumour and regional lymph node involvement. These results indicate that immunohistochemical expression of p53 protein is an important prognostic factor of gastric carcinoma, allowing the selection of a group of patients with an extensive therapeutic indication. Journal of National Institute of Neurosciences Bangladesh, January 2026;12(1):110-114
Observation of Both Early Clinical and Radiological Impacts on Deep-Seated Intracerebral Hemorrhage after Performing Decompressive Craniectomy with Durotomy